Efalizumab for subacute cutaneous lupus: report of two different outcomes. Lupus [Lupus] Journal article

Title	Efalizumab for subacute cutaneous lupus: report of two different outcomes.
Author(s)	Sánchez-Cano D, Callejas-Rubio JL, Ríos-Fernández R, Gutiérrez-Salmerón MT, Pugnaire MA, Ortego-Centeno N
Institution	Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario San Cecilio, Granada, Spain.
Source	Lupus 2009 Oct 30.
Language	ENG
Pub Type(s)	JOURNAL ARTICLE
PubMed ID	19880554

Advertise on this site.